Projects In Knowledge Home

Latest Programs

Expert Insight Into: Localized Palmar-Plantar Epidermal Hyperplasia: A Previously Undiagnosed Dermatologic Toxicity to Sorafenib

Teresa Knoop
Faculty

Oncology Article Review - Cutaneous side effects are a common complication of targeted agents used to treat a variety of malignancies. Teresa J. Knoop, MSN, RN, provides expert commentary on a case report of a patient who developed palmar-plantar epidermal hyperplasia during treatment with sorafenib for the management of metastatic renal cell carcinoma. Importantly, she notes that this dermatologic toxicity may be unique to sorafenib, differing from hand-foot syndrome sometimes associated with chemotherapeutics. more »1

Lessons Learned from STAR*D Study, Levels 1 and 2

Dr. Evans and Dr. Rush
Moderator and Presenter

Psychiatry Audio Interview - A. John Rush, MD, explains the STAR*D study's findings and their implications for clinical practice. Remission was the primary endpoint of the study, which uncovered new information about treatment protocols for people who are initially treatment resistant, as well as how to optimize dosing and wait longer than what current literature suggests in determining whether maximum therapeutic benefit has been reached. Characteristics of people who are more likely to remit or relapse are discussed. Dr. Rush also relates how a simple self-reporting tool can aid clinicians in objectively gauging symptoms and side effects, which can lead to more effective prescribing patterns. This audio interview represents Course 8 of The Advanced Certificate Program: Management of Mood Disorders. more »2

Expert Insight Into: A Placebo-Controlled Evaluation of Adjunctive Modafinil in the Treatment of Bipolar Depression

Dr. Evans
Faculty

Psychiatry Article Review - Dwight L. Evans, MD, reviews the findings from the first placebo-controlled trial of adjunctive modafinil in patients with bipolar disorder, with a focus on bipolar depression. The data suggest a potential for expanded treatment options and subsequent improvements in clinical outcomes. This article review is part of The Advanced Certificate Program: Management of Mood Disorders. more »3

Case Study: Evaluating Viral Breakthrough in an Asian Indian Patient with HBV-related Cirrhosis

Dr. Gish and Dr. Nguyen
Chair and Faculty

Gastroenterology Tx Reporter Newsletter - In this case-based newsletter, Mindie Nguyen, MD, MAS, follows an Asian Indian patient with cirrhosis and HBeAg-negative disease. This case introduces us to the epidemiology of hepatitis B disease within this ethnic population and also highlights issues to consider when switching therapy and interpreting mutational analyses. This is Course 19 of Advanced Certificate Program III: Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities. more »4

Expert Insight Into: Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report

Dr. Evans
Faculty

Psychiatry Article Review - Patients suffering from major depressive disorder are often resistant to initial pharmacotherapy. Alternative, second-step treatment plans are often utilized in order to effectively promote remission. A recent article reports on a study that examined the use of cognitive therapy as a second-step treatment for depression. These findings are reviewed in this course, which features clinical insights by Dwight L. Evans, MD, and is part of The Advanced Certificate Program: Management of Mood Disorders. more »5

Expert Insights—Unexpected Multiple Sclerosis: Follow-up of 30 Patients with Magnetic Resonance Imaging and Clinical Conversion Profile

Dr. DeAngelis
Faculty

Neurology Article Review - The predictive significance of subclinical demyelinating MS lesions and the question of treatment for pre-MS patients are discussed in this review of a recent 5-year follow-up of patients with subclinical lesions meeting the Barkhof-Tintoré criteria for Multiple Sclerosis. Tracy M. DeAngelis, MD, provides expert clinical insights on the study findings. This course is part of The Advanced Certificate Program: Multiple Sclerosis Management. more »6

Expert Insight Into: Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D Report

Dr Thase
Faculty

Psychiatry Article Review - Michael E. Thase, MD, delves into the findings from the STAR*D trial, which focused on treatment and prognosis in patients with anxious versus nonanxious depression. An emphasis on Axis 1 co-morbidities is anchored into the discussion, with implications for best treatment options in real-world practice settings. This article review is part of The Advanced Certificate Program: Management of Mood Disorders. more »7

Expert Insights—Unexpected Multiple Sclerosis: Follow-up of 30 Patients with Magnetic Resonance Imaging and Clinical Conversion Profile

Dr. DeAngelis
Faculty

Neurology Article Review - The predictive significance of subclinical demyelinating MS lesions and the question of treatment for pre-MS patients are discussed in this review of a recent 5-year follow-up of patients with subclinical lesions meeting the Barkhof-TintorÃ© criteria for Multiple Sclerosis. Tracy M. DeAngelis, MD, provides expert clinical insights on the study findings. This course is part of The Advanced Certificate Program: Multiple Sclerosis Management. more »8

Expert Insight Into: Facilitating Oral Chemotherapy Treatment and Compliance Through Patient/Family-Focused Education

Jon Herrington
Faculty

Oncology Article Review - Oral cancer therapy brings about new challenges to oncology clinicians in the areas of patient and family teaching that focus on toxicity management and compliance. This course reviews a recent article that examined these concerns, addressing numerous patient adherence issues and providing guidance on tools to apply to clinical practice. Jon D. Herrington, PharmD, BCPS, BCOP, shares his expert clinical insights on these findings. This article review is part of Caring for Oncology Patients: Tips and Tools for Managing Targeted Therapy. more »9

Expert Insight Into: Hepatitis B Virus DNA Levels at Week 4 of Lamivudine Treatment Predict the 5-Year Ideal Response

Dr. Nguyen
Faculty

Gastroenterology Article Review - A recent study defined the time and level of HBV DNA for predicting patient response after 5 years of lamivudine treatment. These findings could help guide clinicians considering the long-term use of lamivudine in their patients. Mindie Nguyen, MD, MAS, provides expert insights on the important data described in this article review, which represents Course 18 of Advanced Certificate Program III: Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities. more »10


Browse Home » Cardiology » Gastroenterology » Infectious Diseases » Managed Care » Neurology » Oncology » Ophthalmology » Psychiatry » Latest News powered by:	Latest Programs Expert Insight Into: Localized Palmar-Plantar Epidermal Hyperplasia: A Previously Undiagnosed Dermatologic Toxicity to Sorafenib Teresa Knoop Faculty Oncology Article Review - Cutaneous side effects are a common complication of targeted agents used to treat a variety of malignancies. Teresa J. Knoop, MSN, RN, provides expert commentary on a case report of a patient who developed palmar-plantar epidermal hyperplasia during treatment with sorafenib for the management of metastatic renal cell carcinoma. Importantly, she notes that this dermatologic toxicity may be unique to sorafenib, differing from hand-foot syndrome sometimes associated with chemotherapeutics. more »1 Lessons Learned from STARD Study, Levels 1 and 2 Dr. Evans and Dr. Rush Moderator and Presenter Psychiatry Audio Interview* - A. John Rush, MD, explains the STARD study's findings and their implications for clinical practice. Remission was the primary endpoint of the study, which uncovered new information about treatment protocols for people who are initially treatment resistant, as well as how to optimize dosing and wait longer than what current literature suggests in determining whether maximum therapeutic benefit has been reached. Characteristics of people who are more likely to remit or relapse are discussed. Dr. Rush also relates how a simple self-reporting tool can aid clinicians in objectively gauging symptoms and side effects, which can lead to more effective prescribing patterns. This audio interview represents Course 8 of The Advanced Certificate Program: Management of Mood Disorders.* more »2 Expert Insight Into: A Placebo-Controlled Evaluation of Adjunctive Modafinil in the Treatment of Bipolar Depression Dr. Evans Faculty Psychiatry Article Review - Dwight L. Evans, MD, reviews the findings from the first placebo-controlled trial of adjunctive modafinil in patients with bipolar disorder, with a focus on bipolar depression. The data suggest a potential for expanded treatment options and subsequent improvements in clinical outcomes. This article review is part of The Advanced Certificate Program: Management of Mood Disorders. more »3 Case Study: Evaluating Viral Breakthrough in an Asian Indian Patient with HBV-related Cirrhosis Dr. Gish and Dr. Nguyen Chair and Faculty Gastroenterology Tx Reporter Newsletter - In this case-based newsletter, Mindie Nguyen, MD, MAS, follows an Asian Indian patient with cirrhosis and HBeAg-negative disease. This case introduces us to the epidemiology of hepatitis B disease within this ethnic population and also highlights issues to consider when switching therapy and interpreting mutational analyses. This is Course 19 of Advanced Certificate Program III: Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities. more »4 Expert Insight Into: Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STARD Report Dr. Evans Faculty Psychiatry Article Review* - Patients suffering from major depressive disorder are often resistant to initial pharmacotherapy. Alternative, second-step treatment plans are often utilized in order to effectively promote remission. A recent article reports on a study that examined the use of cognitive therapy as a second-step treatment for depression. These findings are reviewed in this course, which features clinical insights by Dwight L. Evans, MD, and is part of The Advanced Certificate Program: Management of Mood Disorders. more »5 Expert Insights—Unexpected Multiple Sclerosis: Follow-up of 30 Patients with Magnetic Resonance Imaging and Clinical Conversion Profile Dr. DeAngelis Faculty Neurology Article Review - The predictive significance of subclinical demyelinating MS lesions and the question of treatment for pre-MS patients are discussed in this review of a recent 5-year follow-up of patients with subclinical lesions meeting the Barkhof-Tintoré criteria for Multiple Sclerosis. Tracy M. DeAngelis, MD, provides expert clinical insights on the study findings. This course is part of The Advanced Certificate Program: Multiple Sclerosis Management. more »6 Expert Insight Into: Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STARD Report Dr Thase Faculty Psychiatry Article Review* - Michael E. Thase, MD, delves into the findings from the STARD trial, which focused on treatment and prognosis in patients with anxious versus nonanxious depression. An emphasis on Axis 1 co-morbidities is anchored into the discussion, with implications for best treatment options in real-world practice settings. This article review is part of The Advanced Certificate Program: Management of Mood Disorders. more »7 Expert Insights—Unexpected Multiple Sclerosis: Follow-up of 30 Patients with Magnetic Resonance Imaging and Clinical Conversion Profile Dr. DeAngelis Faculty Neurology Article Review* - The predictive significance of subclinical demyelinating MS lesions and the question of treatment for pre-MS patients are discussed in this review of a recent 5-year follow-up of patients with subclinical lesions meeting the Barkhof-TintorÃ© criteria for Multiple Sclerosis. Tracy M. DeAngelis, MD, provides expert clinical insights on the study findings. This course is part of The Advanced Certificate Program: Multiple Sclerosis Management. more »8 Expert Insight Into: Facilitating Oral Chemotherapy Treatment and Compliance Through Patient/Family-Focused Education Jon Herrington Faculty Oncology Article Review - Oral cancer therapy brings about new challenges to oncology clinicians in the areas of patient and family teaching that focus on toxicity management and compliance. This course reviews a recent article that examined these concerns, addressing numerous patient adherence issues and providing guidance on tools to apply to clinical practice. Jon D. Herrington, PharmD, BCPS, BCOP, shares his expert clinical insights on these findings. This article review is part of Caring for Oncology Patients: Tips and Tools for Managing Targeted Therapy. more »9 Expert Insight Into: Hepatitis B Virus DNA Levels at Week 4 of Lamivudine Treatment Predict the 5-Year Ideal Response Dr. Nguyen Faculty Gastroenterology Article Review - A recent study defined the time and level of HBV DNA for predicting patient response after 5 years of lamivudine treatment. These findings could help guide clinicians considering the long-term use of lamivudine in their patients. Mindie Nguyen, MD, MAS, provides expert insights on the important data described in this article review, which represents Course 18 of Advanced Certificate Program III: Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities. more »10	Featured Programs Webcast Available Now Targeting the Microtubule in Breast Cancer New Course of The Advanced Certificate Program: Breast Cancer Management A Sea Change in MS Treatment— The Potential of Small Molecules On-Demand Interactive Webcast Available Now Mini- Symposia Unraveling the Complexities of Menopause Management Webcast coming July 15! The Art of Individualized Treatment in the Management of Colorectal Cancer On-Demand Webcast Available Now Translating Clinical Trial Data into the Community Setting: A Case-Based Approach to Metastatic Colorectal Cancer On-Demand Webcast Available Now An Interactive, Case-Based Approach to Targeted Therapies for GIST On-Demand Webcast Available Now The Advanced Certificate Program: Multiple Sclerosis Management Available Now The Advanced Certificate Program: Management of Mood Disorders Register Today Caring for Oncology Patients: Tips and Tools for Managing Targeted Therapy An Ongoing Online CME/CE Curriculum Available Now The Advanced Certificate Program: Lung Cancer Management Register Today! Advanced Certificate Program III: Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities Certificate Program The Advanced Certificate Program: Breast Cancer Management Certificate Program Hepatitis C: From Scientific Foundations to New Vistas in Treatment Webcast Now Available From Science to Practice: Managing CINV and Pain in Breast Cancer Patients On-Demand Webcast Who Moved My PEG? The Changing Future of Anti- HCV Therapy On-Demand Webcast View Today!